Hopewell Therapeutics
PrivateLast Round
Seed
Jun 7, 2023
Momentum Score
75 /100
Company Overview
Hopewell Therapeutics is a biotechnology company that is developing a new generation of tissue-targeted lipid nanoparticles (ttLNPs) to deliver genomic medicines. The company's ttLNP platform originated from a decade of research at Tufts University and is designed to systemically administer and specifically target extrahepatic tissues and cells. Hopewell is building its own internal pipeline, with an initial focus on diseases of the lung, and is also exploring applications in oncology, infectious diseases, rare genetic diseases, and neurological disorders. The company has raised significant seed financing to advance its platform through internal programs and external partnerships.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Advanced Materials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hopewell Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Hopewell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 7, 2023 |
Hopewell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hike Capital | Seed |
| Mass Ave Capital | Seed |
| 5Y Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 50% MoM.
Hopewell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hopewell Therapeutics's valuation, stock price, and market status.
